Rapt Therapeutics Stock Price on February 28, 2024

RAPT Stock  USD 1.08  0.03  2.86%   
If you're considering investing in RAPT Stock, it is important to understand the factors that can impact its price. As of today, the current price of RAPT Therapeutics stands at 1.08, as last reported on the 25th of November, with the highest price reaching 1.12 and the lowest price hitting 1.04 during the day. RAPT Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0964, which implies the company had a -0.0964% return per unit of standard deviation over the last 3 months. RAPT Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check RAPT Therapeutics' Mean Deviation of 5.58, variance of 69.47, and Market Risk Adjusted Performance of 4.37 to confirm the risk estimate we provide.
  
RAPT Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0964

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRAPT

Estimated Market Risk

 8.34
  actual daily
74
74% of assets are less volatile

Expected Return

 -0.8
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average RAPT Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RAPT Therapeutics by adding RAPT Therapeutics to a well-diversified portfolio.

Related Headline

Tyra Biosciences Headline on 28th of February 2024

Filed transaction by Tyra Biosciences Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

RAPT Therapeutics Valuation on February 28, 2024

It is possible to determine the worth of RAPT Therapeutics on a given historical date. On February 28, 2024 RAPT was worth 8.95 at the beginning of the trading date compared to the closed value of 8.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of RAPT Therapeutics stock. Still, in general, we apply an absolute valuation method to find RAPT Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of RAPT Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against RAPT Therapeutics' related companies.
 Open High Low Close Volume
  9.59    9.76    8.91    8.99    1,851,960  
02/28/2024
  8.95    9.10    8.64    8.66    1,708,455  
  8.87    9.24    8.36    8.57    1,915,300  
Backtest RAPT Therapeutics  |  RAPT Therapeutics History  |  RAPT Therapeutics Valuation   PreviousNext  
Open Value
8.95
8.66
Closing Value
33.96
Upside

RAPT Therapeutics Trading Date Momentum on February 28, 2024

On February 29 2024 RAPT Therapeutics was traded for  8.57  at the closing time. The top price for the day was 9.24  and the lowest listed price was  8.36 . The trading volume for the day was 1.9 M. The trading history from February 29, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.04% . The trading delta at closing time against the current closing price is 4.62% .

RAPT Therapeutics Fundamentals Correlations and Trends

By evaluating RAPT Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among RAPT Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. RAPT financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About RAPT Therapeutics Stock history

RAPT Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for RAPT is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in RAPT Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing RAPT Therapeutics stock prices may prove useful in developing a viable investing in RAPT Therapeutics
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Rapt Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 88 people.

RAPT Therapeutics Stock Technical Analysis

RAPT Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of RAPT Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of RAPT Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

RAPT Therapeutics Period Price Range

Low
November 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

RAPT Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

RAPT Therapeutics November 25, 2024 Market Strength

Market strength indicators help investors to evaluate how RAPT Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading RAPT Therapeutics shares will generate the highest return on investment. By undertsting and applying RAPT Therapeutics stock market strength indicators, traders can identify RAPT Therapeutics entry and exit signals to maximize returns

RAPT Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for RAPT Therapeutics' price direction in advance. Along with the technical and fundamental analysis of RAPT Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of RAPT to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for RAPT Stock Analysis

When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.